×
S&P 500   3,891.27 (+1.20%)
DOW   31,295.72 (+0.83%)
QQQ   293.87 (+1.76%)
AAPL   145.82 (+2.03%)
MSFT   267.53 (+0.50%)
META   171.24 (+0.87%)
GOOGL   2,353.60 (+2.71%)
AMZN   116.20 (+1.64%)
TSLA   728.16 (+4.74%)
NVDA   157.80 (+4.30%)
NIO   22.36 (+7.35%)
BABA   123.87 (+3.99%)
AMD   79.10 (+4.98%)
MU   58.49 (+1.95%)
CGC   2.67 (+0.75%)
T   21.17 (+0.38%)
GE   62.40 (+1.35%)
F   11.60 (+4.88%)
DIS   97.06 (+1.02%)
AMC   13.95 (+10.98%)
PFE   53.16 (+0.78%)
PYPL   74.43 (+1.62%)
NFLX   188.85 (+2.60%)
S&P 500   3,891.27 (+1.20%)
DOW   31,295.72 (+0.83%)
QQQ   293.87 (+1.76%)
AAPL   145.82 (+2.03%)
MSFT   267.53 (+0.50%)
META   171.24 (+0.87%)
GOOGL   2,353.60 (+2.71%)
AMZN   116.20 (+1.64%)
TSLA   728.16 (+4.74%)
NVDA   157.80 (+4.30%)
NIO   22.36 (+7.35%)
BABA   123.87 (+3.99%)
AMD   79.10 (+4.98%)
MU   58.49 (+1.95%)
CGC   2.67 (+0.75%)
T   21.17 (+0.38%)
GE   62.40 (+1.35%)
F   11.60 (+4.88%)
DIS   97.06 (+1.02%)
AMC   13.95 (+10.98%)
PFE   53.16 (+0.78%)
PYPL   74.43 (+1.62%)
NFLX   188.85 (+2.60%)
S&P 500   3,891.27 (+1.20%)
DOW   31,295.72 (+0.83%)
QQQ   293.87 (+1.76%)
AAPL   145.82 (+2.03%)
MSFT   267.53 (+0.50%)
META   171.24 (+0.87%)
GOOGL   2,353.60 (+2.71%)
AMZN   116.20 (+1.64%)
TSLA   728.16 (+4.74%)
NVDA   157.80 (+4.30%)
NIO   22.36 (+7.35%)
BABA   123.87 (+3.99%)
AMD   79.10 (+4.98%)
MU   58.49 (+1.95%)
CGC   2.67 (+0.75%)
T   21.17 (+0.38%)
GE   62.40 (+1.35%)
F   11.60 (+4.88%)
DIS   97.06 (+1.02%)
AMC   13.95 (+10.98%)
PFE   53.16 (+0.78%)
PYPL   74.43 (+1.62%)
NFLX   188.85 (+2.60%)
S&P 500   3,891.27 (+1.20%)
DOW   31,295.72 (+0.83%)
QQQ   293.87 (+1.76%)
AAPL   145.82 (+2.03%)
MSFT   267.53 (+0.50%)
META   171.24 (+0.87%)
GOOGL   2,353.60 (+2.71%)
AMZN   116.20 (+1.64%)
TSLA   728.16 (+4.74%)
NVDA   157.80 (+4.30%)
NIO   22.36 (+7.35%)
BABA   123.87 (+3.99%)
AMD   79.10 (+4.98%)
MU   58.49 (+1.95%)
CGC   2.67 (+0.75%)
T   21.17 (+0.38%)
GE   62.40 (+1.35%)
F   11.60 (+4.88%)
DIS   97.06 (+1.02%)
AMC   13.95 (+10.98%)
PFE   53.16 (+0.78%)
PYPL   74.43 (+1.62%)
NFLX   188.85 (+2.60%)
ETR:AFX

Carl Zeiss Meditec Price Target, Predictions & Analyst Ratings

€120.30
+5.05 (+4.38%)
(As of 07/6/2022 12:00 AM ET)
Add
Compare
Today's Range
€114.40
€120.30
50-Day Range
€105.45
€128.20
52-Week Range
€104.55
€202.00
Volume
116,973 shs
Average Volume
94,405 shs
Market Capitalization
$10.76 billion
P/E Ratio
39.97
Dividend Yield
0.78%
Price Target
€181.13

Carl Zeiss Meditec (ETR:AFX) Price Target and Consensus Rating (2022)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Analyst Rating

N/A
Based on 0 Analyst Ratings

Consensus Analyst Price Target

€181.13
High Prediction€215.00
Average Prediction€181.13
Low Prediction€146.00
TypeCurrent
7/7/21 to 7/7/22
1 Month Ago
6/7/21 to 6/7/22
3 Months Ago
4/8/21 to 4/8/22
1 Year Ago
7/7/20 to 7/7/21
Consensus RatingN/A
Buy
Hold
Hold
Strong Buy N/A
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy N/A
1 Buy rating(s)
2 Buy rating(s)
2 Buy rating(s)
Hold N/A
0 Hold rating(s)
3 Hold rating(s)
5 Hold rating(s)
Sell N/A
0 Sell rating(s)
1 Sell rating(s)
1 Sell rating(s)
Consensus Price Target€181.13€187.88€173.75€139.86
Get Carl Zeiss Meditec Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for AFX and its competitors with MarketBeat's FREE daily newsletter.


AFX Stock Analyst Ratings By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

AFX Stock Price Target by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Carl Zeiss Meditec Stock vs. The Competition

TypeCarl Zeiss MeditecMedical Companies
Consensus Rating Score
0.00
2.72
Consensus RatingN/ABuy
News Sentiment RatingNeutral News
Positive News
MarketBeat
Community Rating
Outperform Votes
224
59.73%
Underperform Votes
151
40.27%
Avg. Outperform Votes
167
66.80%
Avg. Underperform Votes
83
33.20%

Historical Carl Zeiss Meditec Price Targets and Ratings

DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
6/27/2022Deutsche Bank Rese...
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Falko Friedrichs
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Set Target€156.00+36.66%
5/16/2022UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Graham Doyle
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Set Target€170.00+45.74%
4/21/2022Hauck and Aufhaeuser
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Alexander Galitsa
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Set Target€215.00+59.02%
2/14/2022HSBC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Oezener Sezgi
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Set Target€146.00+9.77%
2/14/2022Deutsche Bank Aktiengesellschaft
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Friedrichs Falko
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Set Target€210.00+57.89%
12/10/2021Berenberg Bank
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Bardo Scott
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Set Target€180.00+3.72%
12/10/2021Kepler Capital Markets
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reinberg Oliver
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Set Target€180.00+3.72%
8/11/2021Nord/LB
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Fechner Holger
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Set Target€192.00+0.13%
5/17/2021DZ Bank
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingNeutral
4/20/2021Independent Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Set TargetSell€97.00-33.81%
(Data available from 7/7/2017 forward. View 10+ years of historical ratings with our analyst ratings screener.)












Carl Zeiss Meditec Price Target - Frequently Asked Questions

Do MarketBeat users like Carl Zeiss Meditec more than its competitors?

MarketBeat users like Carl Zeiss Meditec stock less than the stock of other Medical companies. 59.73% of MarketBeat users gave Carl Zeiss Meditec an outperform vote while medical companies recieve an average of 66.80% outperform votes by MarketBeat users.

Does Carl Zeiss Meditec's stock price have much upside?

According to analysts, Carl Zeiss Meditec's stock has a predicted upside of 23.76% based on their 12-month price targets.

What analysts cover Carl Zeiss Meditec?

Carl Zeiss Meditec has been rated by Deutsche Bank Rese..., Hauck and Aufhaeuser, and UBS Group in the past 90 days.

This page (ETR:AFX) was last updated on 7/7/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer.